These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14740296)

  • 1. TP53 haplotype-based analysis and incidence of post-angioplasty restenosis.
    Zee RY; Cook NR; Kim CA; Fernandez-Cruz A; Lindpaintner K
    Hum Genet; 2004 Mar; 114(4):386-90. PubMed ID: 14740296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein gene polymorphisms and the incidence of post-angioplasty restenosis.
    Zee RY; Hegener HH; Fernandez-Cruz A; Lindpaintner K
    Atherosclerosis; 2004 Oct; 176(2):393-6. PubMed ID: 15380464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid metabolism and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: role of cholesteryl ester transfer protein and paraoxonase/arylesterase.
    Zee RY; Fernandez-Otiz A; Macaya C; Pintor E; Lindpaintner K; Fernandez-Cruz A
    J Thromb Haemost; 2003 Jun; 1(6):1202-7. PubMed ID: 12871320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 cluster genes and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: a prospective, angiography-based evaluation.
    Zee RY; Fernandez-Ortiz A; Macaya C; Pintor E; Fernandez-Cruz A; Lindpaintner K
    Atherosclerosis; 2003 Dec; 171(2):259-64. PubMed ID: 14644395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis.
    Silvestre-Roig C; Fernández P; Mansego ML; van Tiel CM; Viana R; Anselmi CV; Condorelli G; de Winter RJ; Martín-Fuentes P; Solanas-Barca M; Civeira F; Focaccio A; de Vries CJ; Chaves FJ; Andrés V
    Circ Cardiovasc Genet; 2014 Feb; 7(1):59-70. PubMed ID: 24395923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.
    Beijk MA; Boekholdt SM; Rittersma SZ; Pons D; Zwinderman AH; Doevendans PA; Tio RA; Tijssen JG; Jukema JW; de Winter RJ
    Pharmacogenet Genomics; 2010 Sep; 20(9):544-52. PubMed ID: 20671584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor.
    Schillinger M; Exner M; Minar E; Mlekusch W; Müllner M; Mannhalter C; Bach FH; Wagner O
    J Am Coll Cardiol; 2004 Mar; 43(6):950-7. PubMed ID: 15028349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotypes of the angiotensin-converting enzyme (ACE) gene are associated with coronary artery disease but not with restenosis after coronary stenting.
    Martínez-Ríos MA; Alvarez-León E; Totomoch A; Angeles J; Peña-Duque MA; Delgadillo-Rodríguez H; Martínez-Rodríguez N; Ramírez-Fuentes S; Fragoso JM; Vargas-Alarcón G
    Exp Mol Pathol; 2014 Aug; 97(1):166-70. PubMed ID: 24995885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention.
    Kullmann S; Binner P; Rackebrandt K; Huge A; Haltern G; Lankisch M; Füth R; von Hodenberg E; Bestehorn HP; Scheffold T
    BMC Cardiovasc Disord; 2009 Oct; 9():48. PubMed ID: 19814804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic risk for restenosis after coronary balloon angioplasty.
    Horibe H; Yamada Y; Ichihara S; Watarai M; Yanase M; Takemoto K; Shimizu S; Izawa H; Takatsu F; Yokota M
    Atherosclerosis; 2004 May; 174(1):181-7. PubMed ID: 15135268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions.
    Rudez G; Pons D; Leebeek F; Monraats P; Schrevel M; Zwinderman A; de Winter R; Tio R; Doevendans P; Jukema W; de Maat M
    Hum Mutat; 2008 Mar; 29(3):375-80. PubMed ID: 18175333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty.
    Rauchhaus M; Gross M; Schulz S; Francis DP; Greiser P; Norwig A; Weidhase L; Coats AJ; Dietz R; Anker SD; Gläser C
    Int J Cardiol; 2002 Jun; 83(3):249-57. PubMed ID: 12036529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha plays an important role in restenosis development.
    Monraats PS; Pires NM; Schepers A; Agema WR; Boesten LS; de Vries MR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; 't Hart LM; Frants RR; Quax PH; van Vlijmen BJ; Havekes LM; van der Laarse A; van der Wall EE; Jukema JW
    FASEB J; 2005 Dec; 19(14):1998-2004. PubMed ID: 16319143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
    Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
    Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the tissue factor pathway inhibitor gene and the risk of restenosis after coronary angioplasty.
    Moatti D; Meirhaeghe A; Ollivier V; Bauters C; Amouyel P; de Prost D
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):317-23. PubMed ID: 11460016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement.
    Falcone C; Emanuele E; Buzzi MP; Ballerini L; Repetto A; Canosi U; Mazzucchelli I; Schirinzi S; Sbarsi I; Boiocchi C; Cuccia M
    Int J Immunopathol Pharmacol; 2007; 20(4):771-7. PubMed ID: 18179750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty.
    Schnyder G; Roffi M; Flammer Y; Pin R; Hess OM
    Eur Heart J; 2002 May; 23(9):726-33. PubMed ID: 11977999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention.
    Monraats PS; Fang Y; Pons D; Pires NM; Pols HA; Zwinderman AH; de Maat MP; Doevendans PA; DeWinter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Uitterlinden AG; Jukema JW
    Expert Opin Ther Targets; 2010 Mar; 14(3):243-51. PubMed ID: 20095921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.